Next Up: Well be diving into the Primary Mode of Action (PMOA) the cornerstone of your regulatory pathway
First, reduced efficacy may lead to inadequate blood glucose control in patients with type 2 diabetes, potentially resulting in hyperglycemia and increased risk of diabetic complications
42) In SUSTAIN-6, patients treated with semaglutide had a lower risk of developing or worsening nephropathy, but a higher risk of complications from diabetic retinopathy than those receiving placebo ( In subsequent studies: PIONEER-6 and ELIXA the primary endpoints (death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke, hospitalization for unstable angina) were not met in the GLP-1 RAs group, but a significant decrease in glycated hemoglobin was observed
A second factor is metabolic adaptation
Bundle pricing makes sense if you are committed to the treatment timeline
Diabetes mellitus is classified in categories E08E13 of Chapter 4 (Endocrine, Nutritional and Metabolic Diseases) of the ICD-10-CM FY2026 Tabular List